Myofascial Induction Therapy Improves the Sequelae of Medical Treatment in Head and Neck Cancer Survivors: A Single-Blind, Placebo-Controlled, Randomized Cross-Over Study

Head and neck cancer (HNC) is the sixth most common cancer worldwide. Yet, less than 60% of HNC survivors receive adequate therapy for treatment-related sequelae. The objective of this study was to determine the efficacy of myofascial induction therapy (MIT) in improving cervical and shoulder pain a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Eduardo Castro-Martín, Noelia Galiano-Castillo, Carolina Fernández-Lao, Lucía Ortiz-Comino, Paula Postigo-Martin, Manuel Arroyo-Morales
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	head and neck neoplasms musculoskeletal manipulations pain range of motion Medicine R
Acceso en línea:	https://doaj.org/article/460b77f3e0cf4e54af1edb2dd09374a9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:460b77f3e0cf4e54af1edb2dd09374a9
record_format	dspace
spelling	oai:doaj.org-article:460b77f3e0cf4e54af1edb2dd09374a92021-11-11T17:37:48ZMyofascial Induction Therapy Improves the Sequelae of Medical Treatment in Head and Neck Cancer Survivors: A Single-Blind, Placebo-Controlled, Randomized Cross-Over Study10.3390/jcm102150032077-0383https://doaj.org/article/460b77f3e0cf4e54af1edb2dd09374a92021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/5003https://doaj.org/toc/2077-0383Head and neck cancer (HNC) is the sixth most common cancer worldwide. Yet, less than 60% of HNC survivors receive adequate therapy for treatment-related sequelae. The objective of this study was to determine the efficacy of myofascial induction therapy (MIT) in improving cervical and shoulder pain and range of motion, maximal mouth opening, and cervical muscle function in HNC survivors. This crossover, blinded, placebo-controlled study involved 22 HNC survivors (average age 56.55 ± 12.71) of which 13 were males (59.1%) who received, in a crossover fashion, both a single 30-min session of MIT in the form of manual unwinding and simulated pulsed shortwave therapy (placebo), with a 4-week washout interval between the two. Cervical and shoulder pain (visual analogue scale) and range of motion (cervical range of motion device and goniometer), maximum mouth opening (digital caliper), and cervical muscle function (deep cervical flexor endurance test) were measured before and after the treatment and placebo sessions. A single session of MIT improved cervical and affected side shoulder pain, cervical range of motion, maximum mouth opening, and cervical muscle function. The associated effect sizes ranged from moderate to large. The present study suggests that MIT, in the form of manual unwinding, improves cervical (−3.91 ± 2.77) and affected-side shoulder (−3.64 ± 3.1) pain, cervical range of motion (flexion: 8.41 ± 8.26 deg; extension: 12.23 ± 6.55; affected-side rotation: 14.27 ± 11.05; unaffected-side rotation: 11.73 ± 8.65; affected-side lateroflexion: 7.95 ± 5.1; unaffected-side lateroflexion: 9.55 ± 6.6), maximum mouth opening (3.36 ± 3.4 mm), and cervical muscle function (8.09 ± 6.96 s) in HNC survivors.Eduardo Castro-MartínNoelia Galiano-CastilloCarolina Fernández-LaoLucía Ortiz-CominoPaula Postigo-MartinManuel Arroyo-MoralesMDPI AGarticlehead and neck neoplasmsmusculoskeletal manipulationspainrange of motionMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5003, p 5003 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	head and neck neoplasms musculoskeletal manipulations pain range of motion Medicine R
spellingShingle	head and neck neoplasms musculoskeletal manipulations pain range of motion Medicine R Eduardo Castro-Martín Noelia Galiano-Castillo Carolina Fernández-Lao Lucía Ortiz-Comino Paula Postigo-Martin Manuel Arroyo-Morales Myofascial Induction Therapy Improves the Sequelae of Medical Treatment in Head and Neck Cancer Survivors: A Single-Blind, Placebo-Controlled, Randomized Cross-Over Study
description	Head and neck cancer (HNC) is the sixth most common cancer worldwide. Yet, less than 60% of HNC survivors receive adequate therapy for treatment-related sequelae. The objective of this study was to determine the efficacy of myofascial induction therapy (MIT) in improving cervical and shoulder pain and range of motion, maximal mouth opening, and cervical muscle function in HNC survivors. This crossover, blinded, placebo-controlled study involved 22 HNC survivors (average age 56.55 ± 12.71) of which 13 were males (59.1%) who received, in a crossover fashion, both a single 30-min session of MIT in the form of manual unwinding and simulated pulsed shortwave therapy (placebo), with a 4-week washout interval between the two. Cervical and shoulder pain (visual analogue scale) and range of motion (cervical range of motion device and goniometer), maximum mouth opening (digital caliper), and cervical muscle function (deep cervical flexor endurance test) were measured before and after the treatment and placebo sessions. A single session of MIT improved cervical and affected side shoulder pain, cervical range of motion, maximum mouth opening, and cervical muscle function. The associated effect sizes ranged from moderate to large. The present study suggests that MIT, in the form of manual unwinding, improves cervical (−3.91 ± 2.77) and affected-side shoulder (−3.64 ± 3.1) pain, cervical range of motion (flexion: 8.41 ± 8.26 deg; extension: 12.23 ± 6.55; affected-side rotation: 14.27 ± 11.05; unaffected-side rotation: 11.73 ± 8.65; affected-side lateroflexion: 7.95 ± 5.1; unaffected-side lateroflexion: 9.55 ± 6.6), maximum mouth opening (3.36 ± 3.4 mm), and cervical muscle function (8.09 ± 6.96 s) in HNC survivors.
format	article
author	Eduardo Castro-Martín Noelia Galiano-Castillo Carolina Fernández-Lao Lucía Ortiz-Comino Paula Postigo-Martin Manuel Arroyo-Morales
author_facet	Eduardo Castro-Martín Noelia Galiano-Castillo Carolina Fernández-Lao Lucía Ortiz-Comino Paula Postigo-Martin Manuel Arroyo-Morales
author_sort	Eduardo Castro-Martín
title	Myofascial Induction Therapy Improves the Sequelae of Medical Treatment in Head and Neck Cancer Survivors: A Single-Blind, Placebo-Controlled, Randomized Cross-Over Study
title_short	Myofascial Induction Therapy Improves the Sequelae of Medical Treatment in Head and Neck Cancer Survivors: A Single-Blind, Placebo-Controlled, Randomized Cross-Over Study
title_full	Myofascial Induction Therapy Improves the Sequelae of Medical Treatment in Head and Neck Cancer Survivors: A Single-Blind, Placebo-Controlled, Randomized Cross-Over Study
title_fullStr	Myofascial Induction Therapy Improves the Sequelae of Medical Treatment in Head and Neck Cancer Survivors: A Single-Blind, Placebo-Controlled, Randomized Cross-Over Study
title_full_unstemmed	Myofascial Induction Therapy Improves the Sequelae of Medical Treatment in Head and Neck Cancer Survivors: A Single-Blind, Placebo-Controlled, Randomized Cross-Over Study
title_sort	myofascial induction therapy improves the sequelae of medical treatment in head and neck cancer survivors: a single-blind, placebo-controlled, randomized cross-over study
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/460b77f3e0cf4e54af1edb2dd09374a9
work_keys_str_mv	AT eduardocastromartin myofascialinductiontherapyimprovesthesequelaeofmedicaltreatmentinheadandneckcancersurvivorsasingleblindplacebocontrolledrandomizedcrossoverstudy AT noeliagalianocastillo myofascialinductiontherapyimprovesthesequelaeofmedicaltreatmentinheadandneckcancersurvivorsasingleblindplacebocontrolledrandomizedcrossoverstudy AT carolinafernandezlao myofascialinductiontherapyimprovesthesequelaeofmedicaltreatmentinheadandneckcancersurvivorsasingleblindplacebocontrolledrandomizedcrossoverstudy AT luciaortizcomino myofascialinductiontherapyimprovesthesequelaeofmedicaltreatmentinheadandneckcancersurvivorsasingleblindplacebocontrolledrandomizedcrossoverstudy AT paulapostigomartin myofascialinductiontherapyimprovesthesequelaeofmedicaltreatmentinheadandneckcancersurvivorsasingleblindplacebocontrolledrandomizedcrossoverstudy AT manuelarroyomorales myofascialinductiontherapyimprovesthesequelaeofmedicaltreatmentinheadandneckcancersurvivorsasingleblindplacebocontrolledrandomizedcrossoverstudy
_version_	1718432059460943872

Myofascial Induction Therapy Improves the Sequelae of Medical Treatment in Head and Neck Cancer Survivors: A Single-Blind, Placebo-Controlled, Randomized Cross-Over Study

Ejemplares similares